Medfinder
Back to blog

Updated: January 18, 2026

Pylera Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Calendar with medication availability update illustration

Pylera isn't on the official FDA shortage list, but patients still struggle to find it. Here's the full picture on Pylera availability, pricing barriers, and what to do right now.

If you've been searching for Pylera at your pharmacy and coming up empty-handed, you're not alone. Patients across the United States report difficulty locating this H. pylori treatment in 2026. But the situation is more nuanced than a simple drug shortage — and understanding the full picture can help you get your prescription filled faster.

Is Pylera Currently on the FDA Shortage List?

As of 2026, Pylera (bismuth subcitrate potassium/metronidazole/tetracycline) is not listed on the FDA's official Drug Shortages Database. This means no manufacturer has formally notified the FDA of a production or supply interruption for this drug.

However, the FDA's shortage list is a lagging indicator. It only captures reported shortages — it doesn't reflect real-time pharmacy shelf availability across tens of thousands of retail locations. Being off the shortage list doesn't mean every pharmacy has Pylera in stock.

What's Actually Happening With Pylera Supply in 2026?

The difficulty patients face in finding Pylera is driven primarily by economic factors rather than a manufacturing crisis:

High retail price: At approximately $300–$400 per 10-day course without insurance, Pylera is expensive. Many patients cannot afford it, which depresses demand and gives pharmacies less incentive to stock it.

Insurance coverage gaps: Many insurance formularies, including some Medicare Part D plans, do not cover Pylera or place it on high-cost tiers requiring prior authorization. This creates a cycle: low coverage leads to fewer fills, which leads to lower pharmacy stock.

Narrow distribution: Pylera is manufactured by H2 Pharma and distributed through a narrower network compared to high-volume generic drugs. Regional gaps in distribution can leave certain areas with limited access.

Infrequent prescribing patterns: Many gastroenterologists prescribe the individual components of bismuth quadruple therapy separately (as cheaper generics) rather than the branded Pylera capsule. This reduces demand for Pylera specifically.

Has Pylera Been in Shortage Before?

Pylera has had periods of inconsistent availability at retail pharmacies historically. The core challenge has always been more about economics than manufacturing — bismuth salts and tetracycline have both experienced supply-chain disruptions at various points that can ripple through availability, but these don't necessarily rise to the level of a formal FDA-reported shortage for the combined Pylera product.

The fact that a generic version of Pylera has received FDA approval adds another layer of complexity — generic availability can be inconsistent, meaning some pharmacies have the brand, some have the generic, and some have neither.

What Does This Mean for You as a Patient?

If you've been prescribed Pylera, here is the practical reality:

Your local pharmacy may not stock Pylera — this is not necessarily a global shortage, just a local inventory decision

Larger chain pharmacies (CVS, Walgreens, Walmart) are more likely to have it in stock than small independents

A pharmacy that doesn't have it today can often special-order it within 24–48 hours from their drug distributor

Using a GoodRx or SingleCare coupon can reduce the price to approximately $187–$200, which may make it more viable for you and more worthwhile for a pharmacy to order

Is H. pylori Treatment Still Effective Without Pylera?

Yes. Pylera is one of the more convenient forms of bismuth-based quadruple therapy, but it's not the only option. The 2024 ACG guidelines designate optimized bismuth quadruple therapy (BQT) as the preferred first-line H. pylori treatment — and BQT can be administered as separate generic components without relying on the Pylera capsule. Eradication rates of 90–97% have been reported with 10-14 days of properly administered bismuth quadruple therapy.

Other FDA-approved options include Talicia (rifabutin-based triple therapy) and vonoprazan-based regimens (Voquezna). See our guide to Pylera alternatives for a full comparison.

What Should I Do If I Can't Find Pylera?

Use medfinder — enter your medication, dosage, and zip code, and medfinder contacts pharmacies near you to find which ones have Pylera in stock. No hold music, no repeated phone calls. Results are texted to you directly.

You can also ask your pharmacist to special-order Pylera, check prices with discount cards, or talk to your doctor about switching to the generic components or an alternative regimen. The most important step is not delaying your H. pylori treatment indefinitely.

How to Stay Informed on Pylera Availability

To stay informed on Pylera availability:

Check the FDA Drug Shortages Database at accessdata.fda.gov for official shortage announcements

Check the ASHP (American Society of Health-System Pharmacists) shortage database for additional clinical reporting

Ask your pharmacist directly — they often have the most current real-time information on what they have in stock and when they can get more

Frequently Asked Questions

No. As of 2026, Pylera is not listed on the FDA's official Drug Shortages Database. However, many pharmacies don't routinely stock it due to its high price and relatively low prescription demand. Being off the shortage list doesn't mean it's easy to find at every pharmacy.

The main reasons are economic rather than manufacturing-related: Pylera is expensive ($300–$400 per course), many insurance plans don't cover it well, and prescription volume is low compared to common medications. Pharmacies with low demand for a drug tend not to keep it on shelves regularly.

Use medfinder to find pharmacies near you with Pylera in stock. You can also ask your current pharmacy to special-order it (usually 24–48 hours). Apply a GoodRx or SingleCare coupon to bring the price to around $187–$200. If Pylera remains unavailable, ask your doctor about prescribing the same active ingredients as separate generics.

Tetracycline, one of the active ingredients in Pylera, has had intermittent supply issues at various times. However, as of 2026, no component of Pylera's standard quadruple therapy regimen is listed as an active FDA shortage. Availability can vary by region and pharmacy, so check with your local pharmacist.

Availability of Pylera is more closely tied to market economics than to supply-chain disruptions. Without major changes in insurance coverage or pricing, the availability pattern in 2026 is likely to remain similar — available at larger chain pharmacies and hospital outpatient pharmacies, but inconsistently stocked at smaller independents.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Pylera also looked for:

30,038 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,038 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?